FDA Inspection 1249006 — Wuh-Liang Hwu, MD, PhD
The FDA completed an inspection of Wuh-Liang Hwu, MD, PhD on Aug 30, 2024 in Taipei. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 30, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Taipei (Taiwan)
Additional Details
Sponsor-Investigator (S-I)